Juno | Omega appoints Jean-Guy Goulet,
a senior executive
with a proven track record
in the Canadian generic pharmaceutical industry, to the
position of Chief Executive Officer.
MONTREAL, May 7, 2024
/CNW/ -
The Board of Juno Pharmaceuticals Corporation is excited
to announce the appointment of Jean-Guy
Goulet as Chief Executive Officer (CEO).
An executive with over 35 years of experience in the
pharmaceutical industry, overseeing activities in Canada and abroad, Jean-Guy is an effective
and driven executive whose organizations have consistently
delivered and outperformed in the generic pharmaceutical industry.
The common thread throughout his career
is his ability to focus the strengths of his sales,
operations, and logistics teams on common objectives
to deliver exceptional service levels to customers, outstanding
results for shareholders, and unparalleled growth opportunities for
his colleagues.
"I am honoured to join another great Canadian company with
domestic and international growth
ambitions," said Jean-Guy. " I deeply
believe in the value of local transformation for the Canadian
pharmaceutical landscape, and I look forward to working with our amazing
teams in Montreal and Toronto to propel Juno | Omega to a whole new
level."
Jean-Guy's appointment reflects Juno | Omega's
commitment to build on its core strengths
and reach its full potential as an organization. His
comprehensive experience, participative leadership style, and
ability to create a strong culture and identity, which will help
the company surge ahead on its path to more success.
"We are thrilled to welcome Jean-Guy
to our executive team as CEO," said Ian Jacobson, Chair of Juno
Pharmaceuticals Corporation. "His leadership, proven track record,
and extensive network, both in Canada and around the world, will contribute
significantly to the realization of our ambitious vision for the
company."
About Juno | Omega
Juno Pharmaceuticals Corporation is a leader
in the commercialization of specialty pharmaceuticals and
owner of Omega Laboratories Ltd, one of Canada's largest
domestic specialty injectable pharmaceutical
manufacturers. Juno | Omega ranks among Canada's most prominent specialty generic
injectable businesses with domestic manufacturing capabilities.
Through local manufacturing and international partnerships, Juno |
Omega improves the supply of high-quality medications in numerous
therapeutic areas. Planning to introduce over 100 new products in
the coming years, Juno | Omega is establishing itself as
Canada's fastest-growing domestic
specialty pharmaceutical business.
SOURCE Juno Pharmaceuticals